132 related articles for article (PubMed ID: 30990126)
1. Experimental study and mathematical modeling for encapsulation of fentanyl citrate drug in nanostructured lipid carrier.
Bahrami MA; Farhadian N
J Biomol Struct Dyn; 2020 Mar; 38(5):1263-1271. PubMed ID: 30990126
[TBL] [Abstract][Full Text] [Related]
2. Enhanced bactericidal effect of ceftriaxone drug encapsulated in nanostructured lipid carrier against gram-negative Escherichia coli bacteria: drug formulation, optimization, and cell culture study.
Ebrahimi S; Farhadian N; Karimi M; Ebrahimi M
Antimicrob Resist Infect Control; 2020 Feb; 9(1):28. PubMed ID: 32041660
[TBL] [Abstract][Full Text] [Related]
3. Improvement of Pain Relief of Fentanyl Citrate Drug Encapsulated in Nanostructured Lipid Carrier: Drug Formulation, Parameter Optimization, in vitro and in vivo Studies.
Bahrami MA; Farhadian N; Karimi M; Forouzan A; Masoumi K
Drug Des Devel Ther; 2020; 14():2033-2045. PubMed ID: 32546968
[TBL] [Abstract][Full Text] [Related]
4. Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers.
Thatipamula R; Palem C; Gannu R; Mudragada S; Yamsani M
Daru; 2011; 19(1):23-32. PubMed ID: 22615636
[TBL] [Abstract][Full Text] [Related]
5. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy.
Cirri M; Maestrini L; Maestrelli F; Mennini N; Mura P; Ghelardini C; Di Cesare Mannelli L
Drug Deliv; 2018 Nov; 25(1):1910-1921. PubMed ID: 30451015
[TBL] [Abstract][Full Text] [Related]
6. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
Khan S; Baboota S; Ali J; Narang RS; Narang JK
Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
[TBL] [Abstract][Full Text] [Related]
7. Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization.
Shete H; Patravale V
Int J Pharm; 2013 Sep; 454(1):573-83. PubMed ID: 23535345
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus-loaded nanostructured lipid carriers for oral delivery - Optimization of production and characterization.
Khan S; Shaharyar M; Fazil M; Baboota S; Ali J
Eur J Pharm Biopharm; 2016 Nov; 108():277-288. PubMed ID: 27449630
[TBL] [Abstract][Full Text] [Related]
9. Design and evaluations of a nanostructured lipid carrier loaded with dopamine hydrochloride for intranasal bypass drug delivery in Parkinson's disease.
Neha SL; Mishra AK; Rani L; Paroha S; Dewangan HK; Sahoo PK
J Microencapsul; 2023 Dec; 40(8):599-612. PubMed ID: 37787159
[TBL] [Abstract][Full Text] [Related]
10. Preparation, optimization and characteristic of huperzine a loaded nanostructured lipid carriers.
Yang CR; Zhao XL; Hu HY; Li KX; Sun X; Li L; Chen DW
Chem Pharm Bull (Tokyo); 2010 May; 58(5):656-61. PubMed ID: 20460792
[TBL] [Abstract][Full Text] [Related]
11. Nanostructured lipid carriers for the encapsulation of phloretin: preparation and in vitro characterization studies.
Gu L; Sun R; Wang W; Xia Q
Chem Phys Lipids; 2022 Jan; 242():105150. PubMed ID: 34673008
[TBL] [Abstract][Full Text] [Related]
12. Topical phenytoin nanostructured lipid carriers: design and development.
Motawea A; Borg T; Abd El-Gawad AEH
Drug Dev Ind Pharm; 2018 Jan; 44(1):144-157. PubMed ID: 28956451
[TBL] [Abstract][Full Text] [Related]
13. Design and characterization of Nanostructured lipid carriers (NLC) and Nanostructured lipid carrier-based hydrogels containing Passiflora edulis seeds oil.
Krambeck K; Silva V; Silva R; Fernandes C; Cagide F; Borges F; Santos D; Otero-Espinar F; Lobo JMS; Amaral MH
Int J Pharm; 2021 May; 600():120444. PubMed ID: 33713760
[TBL] [Abstract][Full Text] [Related]
14. Formulation development of lipid nanoparticles: Improved lipid screening and development of tacrolimus loaded nanostructured lipid carriers (NLC).
Kovačević AB; Müller RH; Keck CM
Int J Pharm; 2020 Feb; 576():118918. PubMed ID: 31870954
[TBL] [Abstract][Full Text] [Related]
15. Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation.
Mennini N; Cirri M; Maestrelli F; Mura P
Int J Pharm; 2016 Dec; 515(1-2):684-691. PubMed ID: 27825863
[TBL] [Abstract][Full Text] [Related]
16. [Formulation optimization of emodin nanostructured lipid carriers by Box-Behnken response surface method and in vitro quality evaluation].
Han DE; Xin YF; Wei HC; Zhu XL; Liu YM; Tian P
Zhongguo Zhong Yao Za Zhi; 2022 Feb; 47(4):913-921. PubMed ID: 35285190
[TBL] [Abstract][Full Text] [Related]
17. Sildenafil citrate-loaded targeted nanostructured lipid carrier enhances receptivity potential of endometrial cells via LIF and VEGF upregulation.
Hajipour H; Sambrani R; Ghorbani M; Mirzamohammadi Z; Nouri M
Naunyn Schmiedebergs Arch Pharmacol; 2021 Nov; 394(11):2323-2331. PubMed ID: 34515834
[TBL] [Abstract][Full Text] [Related]
18. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry.
Castelli F; Puglia C; Sarpietro MG; Rizza L; Bonina F
Int J Pharm; 2005 Nov; 304(1-2):231-8. PubMed ID: 16188405
[TBL] [Abstract][Full Text] [Related]
19. Development and Optimisation of Spironolactone Nanoparticles for Enhanced Dissolution Rates and Stability.
Kelidari HR; Saeedi M; Akbari J; Morteza-Semnani K; Valizadeh H; Maniruzzaman M; Farmoudeh A; Nokhodchi A
AAPS PharmSciTech; 2017 Jul; 18(5):1469-1474. PubMed ID: 27834054
[TBL] [Abstract][Full Text] [Related]
20. Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics in treatment of psoriasis: a comparative study.
Arora R; Katiyar SS; Kushwah V; Jain S
Expert Opin Drug Deliv; 2017 Feb; 14(2):165-177. PubMed ID: 27882780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
